Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.
Autor: | Tortajada C, Pérez-Cuevas B, Moreno A, Martínez E, Mallolas J, García F, Valls E, Miró JM, De Lazzari E, Gatell JM |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2002 Jul 01; Vol. 30 (3), pp. 364-6. |
DOI: | 10.1097/00126334-200207010-00015 |
Databáze: | MEDLINE |
Externí odkaz: |